Beyond Serialization to Business Value

As part of Epista's mission to continuously improve regulatory compliance, we are proud to announce our listing as a Representative Vendor in Gartner’s recent Market Guide Track-and-Trace and Serialization Providers in Life Sciences and Healthcare Value Chain (1).  

The report highlights the importance of moving beyond compliance to create business value. One of the report’s key recommendations urges supply chain leaders responsible for technology to “extend well beyond compliance obligations by assessing software and services for track-and-trace and serialization in their ability to deliver results and value in areas such as change management, peer networking, digital and IoT foundations.”

This focus is the foundation of Epista’s service in the manufacturing area. According to Klavs Esbjerg, CEO of Epista Life Science:

“We believe our inclusion in Gartner’s Market Guide validates why our clients rely on and trust Epista. It’s based on our expertise in the regulatory compliance of serialization solutions, the program management of business processes, and the implementation of new technology - with an eye towards the future. Serialization programs are only the first steps towards our client’s ultimate digitalization goals. It’s all about defining these goals, and even more importantly, creating a digital roadmap to reach them.”

If you’re looking to get to market faster with lower risk, read about our Biotech Accelerator Solution here.